CarepathRx, a Mercer Island-based pharmacy management company, announced its plans to acquire part of the specialty pharmacy operations of Chartwell, a subsidiary of UPMC of Pittsburgh, in a deal valued at $400 million. UPMC will become a strategic investor in CarepathRx as part of the acquisition. "Our partnership with UPMC and Chartwell is an important step for CarepathRx," CarepathRx CEO and founder John Figueroa said in a press release. "We set out to create a new approach to pharmacy care in...
